New Fashion Design for DIOSMECTITE - Amoxicillin Sodium+Sulbactam Sodium – Golden Everbest

Short Description:

Amoxicillin sodium and sulbactam sodium for injection, the indication for this product contains β-lactamase inhibitor-sulbactam, which is suitable for the following infectious diseases caused by enzyme-producing bacteria. Main Specs: 2：1 Standard: BP/USP/CP Certificates: GMP

Send email to us Download as PDF

Product Detail

Product Tags

Feedback (2)

"Quality initially, Honesty as base, Sincere company and mutual profit" is our idea, in order to create repeatedly and pursue the excellence for Mesotrione , Dinotefuran , Aspirin , If you are interested in any of our products or would like to discuss a custom order, please feel free to contact us.

New Fashion Design for DIOSMECTITE - Amoxicillin Sodium+Sulbactam Sodium – Golden Everbest Detail:

Main Specs:

2：1

Standard:

BP/USP/CP

Certificates:

GMP

Product detail pictures:

Related Product Guide:

Using a full scientific good quality administration system, very good quality and superior faith, we win good standing and occupied this discipline for New Fashion Design for DIOSMECTITE - Amoxicillin Sodium+Sulbactam Sodium – Golden Everbest, The product will supply to all over the world, such as: Vietnam , San Francisco , Mauritius , Facing fierce global market competition, we have launched the brand building strategy and updated the spirit of "human-oriented and faithful service", with an aim to gain global recognition and sustainable development.

52-01-7

70288-86-7

DIBUTYL PHTHALATE

Iprodione

Sucralose Powder Price

Water Soluble Paprika Oleoresin

The quality of the products is very good, especially in the details, can be seen that the company work actively to satisfy customer's interest, a nice supplier.

By Madge from venezuela - 2018.06.05 13:10

We have been engaged in this industry for many years, we appreciate the work attitude and production capacity of the company, this is a reputable and professional manufacturer.

By Anna from luzern - 2017.05.02 18:28